News

Feds abandon fight for graphic cigarette labels


 

The Food and Drug Administration, facing virulent opposition from the tobacco industry as well as two court decisions that didn’t go its way, has decided to drop its proposals to include graphic, photo-based warning labels on cigarette packs.

Courtesy U.S. Food and Drug Administration

The FDA has decided to drop its proposals to include graphic, photo-based warning labels on cigarette packs.

Instead, the FDA said it will research new ways to craft warning labels that can reduce tobacco deaths, while still satisfying the courts’ requirements that any regulations not infringe upon tobacco companies’ First Amendment right to free speech. The 2009 Tobacco Control Act requires the FDA to implement new warning labels.

The graphic warning labels, first unveiled in 2011 and intended for placement on all cigarette packages, included disturbing photos such as the corpse of a man who died of tobacco-related causes, disease-riddled lungs, and rotting teeth. Other countries use similar warning labels.

A group of tobacco manufacturers sued the agency to overturn the requirement to use the labels, and two courts – most recently, the U.S. Court of Appeals for the D.C. Circuit – sided with the manufacturers. The Justice Department elected not to appeal the case to the U.S. Supreme Court.

The American Cancer Society Cancer Action Network, the ACS’ advocacy arm, urged the FDA to work quickly to develop new graphic warnings. "The current warning labels have not been changed in 25 years and are widely considered to be ineffective," group president Chris Hansen said in a statement. "Every day that the current warnings remain in place is another day in which ... the health of the nation is compromised."

Recommended Reading

Efforts to improve mental health disparities underway
MDedge Internal Medicine
PCPs drive reduction in Cleveland hospitalizations
MDedge Internal Medicine
Use of electronic cigarettes on the rise
MDedge Internal Medicine
No drop in employer-based health coverage in 2012
MDedge Internal Medicine
FDA issues warning on azithromycin arrhythmia risk
MDedge Internal Medicine
U.S. health care spending topped $1.2 trillion in 2010
MDedge Internal Medicine
Survey: How appearance counts in ICU
MDedge Internal Medicine
Survey exposes physician frustrations with EHRs
MDedge Internal Medicine
CMS sets aggressive 2013 meaningful use targets
MDedge Internal Medicine
MOC will be focus for new ABIM president
MDedge Internal Medicine